Vanda Pharmaceuticals
VNDA
#8815
Rank
โ‚น21.76 B
Marketcap
โ‚น359.86
Share price
-6.42%
Change (1 day)
-6.02%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2026 (TTM): -โ‚น17.16 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are โ‚น0.21 Billion. In 2025 the company made an earning of -โ‚น14.36 Billion a decrease over its 2024 earnings that were of -โ‚น3.87 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น17.16 Billion19.51%
2025 -โ‚น14.36 Billion271.79%
2024 -โ‚น3.87 Billion191.43%
2023 -โ‚น1.33 Billion-320.45%
2022 โ‚น0.60 B-84.99%
2021 โ‚น4.00 B54.8%
2020 โ‚น2.58 B19.42%
2019 โ‚น2.16 B4.93%
2018 โ‚น2.06 B-228.6%
2017 -โ‚น1.61 Billion-8.98%
2016 -โ‚น1.77 Billion-53.79%
2015 -โ‚น3.82 Billion-30.18%
2014 -โ‚น5.47 Billion173.08%
2013 -โ‚น2.01 Billion-25.33%
2012 -โ‚น2.68 Billion163.61%
2011 -โ‚น1.02 Billion-221.15%
2010 โ‚น0.83 B-124.53%
2009 -โ‚น3.43 Billion-29.44%
2008 -โ‚น4.85 Billion-36.2%
2007 -โ‚น7.6 Billion21.81%
2006 -โ‚น6.24 Billion170.55%
2005 -โ‚น2.31 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.488 T-14,215.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.473 T-8,459.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น655.81 B-3,820.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น3.189 T-18,194.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น730.16 B-4,241.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น1.130 T-6,514.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-โ‚น0.27 Billion-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA